In contrast, the same cell-impermeable pan-kinase inhibitor targets a different and as of yet unidentified molecule or molecules present on the cell surface, independent of viral exposure, which upregulate GPC1 to enhance HIV-1 infection. Here, GPC1 is linked to HIV-1 infection.